BD to Offer Drug Candidate ADME Screening with BioTrove System | GenomeWeb
NEW YORK (GenomeWeb News) – BioTrove said today that Becton Dickinson will offer BioTrove’s mass spectrometry-based screening and analysis system as part of its ADME analysis services for pharmaceutical and biotech companies
 
Under the agreement, BD will offer BioTrove’s mass spec-based RapidFire Technology as part of its drug absorption, distribution, metabolism, and elimination services offering.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Harold Varmus, a former NIH director, says that proposed reductions to the agency's budget are worrisome.

The Genome 10K project is to sequence about 10,000 vertebrate genomes, including ones of endangered species, Digital Trends reports.

The new Coalition to Save NIH Funding aims to educate lawmakers and the public on the significance of biomedical research.

In PLOS this week: analysis of viral sequences from human blood samples, gut microbiomes of heart failure patients, and more.